相似文献
1
Circulating tumour cells as a predictive factor for response to systemic chemotherapy in patients with advanced colorectal cancer.
Mol Oncol. 2008 Dec;2(4):349-55. doi: 10.1016/j.molonc.2008.09.001. Epub 2008 Sep 16.
2
Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents.
Ann Oncol. 2010 May;21(5):1006-12. doi: 10.1093/annonc/mdp463. Epub 2009 Oct 27.
3
A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer.
Int J Cancer. 2014 Dec 1;135(11):2633-43. doi: 10.1002/ijc.28910. Epub 2014 Apr 29.
4
Prognostic value of the combination of circulating tumor cells plus KRAS in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumab.
Clin Colorectal Cancer. 2013 Dec;12(4):280-6. doi: 10.1016/j.clcc.2013.06.001. Epub 2013 Sep 5.
5
Longitudinal monitoring reveals dynamic changes in circulating tumor cells (CTCs) and CTC-associated miRNAs in response to chemotherapy in metastatic colorectal cancer patients.
Cancer Lett. 2018 Jun 1;423:1-8. doi: 10.1016/j.canlet.2018.02.039. Epub 2018 Mar 5.
6
The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab.
Ann Oncol. 2010 Dec;21(12):2447-2448. doi: 10.1093/annonc/mdq640. Epub 2010 Oct 28.
7
Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: a pilot study.
Clin Transl Oncol. 2010 Feb;12(2):142-7. doi: 10.1007/S12094-010-0479-7.
8
Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab.
Ann Oncol. 2017 Jan 1;28(1):103-109. doi: 10.1093/annonc/mdw535.
9
Clinico-pathological correlation of serial measurement of circulating tumor cells in 24 metastatic colorectal cancer patients receiving chemotherapy reveals interpatient heterogeneity correlated with CEA levels but independent of KRAS and BRAF mutation.
Cancer Biol Ther. 2015;16(5):709-13. doi: 10.1080/15384047.2015.1030555.
10
Circulating tumour cells in locally advanced head and neck cancer: preliminary report about their possible role in predicting response to non-surgical treatment and survival.
Eur J Cancer. 2012 Nov;48(16):3019-26. doi: 10.1016/j.ejca.2012.05.007. Epub 2012 Jun 7.
引用本文的文献
1
Circulating Tumor Cells in Colorectal Cancer: Detection Systems and Clinical Utility.
Int J Mol Sci. 2022 Nov 5;23(21):13582. doi: 10.3390/ijms232113582.
2
Clinical Significance of Circulating Tumor Cells in Gastrointestinal Carcinomas.
Diagnostics (Basel). 2020 Mar 30;10(4):192. doi: 10.3390/diagnostics10040192.
3
PrediCTC, liquid biopsy in precision oncology: a technology transfer experience in the Spanish health system.
Clin Transl Oncol. 2018 May;20(5):630-638. doi: 10.1007/s12094-017-1760-9. Epub 2017 Oct 20.
4
Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells.
Onco Targets Ther. 2016 Dec 13;9:7503-7513. doi: 10.2147/OTT.S115268. eCollection 2016.
5
CTC enumeration and characterization: moving toward personalized medicine.
Ann Transl Med. 2014 Nov;2(11):108. doi: 10.3978/j.issn.2305-5839.2014.09.06.
6
Fourier ptychographic microscopy for filtration-based circulating tumor cell enumeration and analysis.
J Biomed Opt. 2014 Jun;19(6):066007. doi: 10.1117/1.JBO.19.6.066007.
7
Circulating tumor cells: exploring intratumor heterogeneity of colorectal cancer.
Cancer Biol Ther. 2014 May;15(5):496-503. doi: 10.4161/cbt.28020. Epub 2014 Feb 12.
8
Biology and significance of circulating and disseminated tumour cells in colorectal cancer.
Langenbecks Arch Surg. 2012 Apr;397(4):535-42. doi: 10.1007/s00423-012-0917-9. Epub 2012 Feb 15.
9
Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.
J Cancer Res Clin Oncol. 2011 Aug;137(8):1151-73. doi: 10.1007/s00432-011-0988-y. Epub 2011 Jun 17.
10
Correlation between Cancer Stem Cells and Circulating Tumor Cells and Their Value.
Case Rep Oncol. 2011 Jan 29;4(1):44-54. doi: 10.1159/000324403.
本文引用的文献
1
Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells.
Cell Oncol. 2008;30(6):463-71. doi: 10.3233/clo-2008-0432.
2
Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer.
Anticancer Res. 2007 Jul-Aug;27(4A):1823-32.
3
Current role of antibody therapy in patients with metastatic colorectal cancer.
Oncogene. 2007 May 28;26(25):3661-78. doi: 10.1038/sj.onc.1210377.
4
Novel approaches to treatment of advanced colorectal cancer with anti-EGFR monoclonal antibodies.
Ann Med. 2006;38(8):545-51. doi: 10.1080/09546630601070812.
5
Lack of the type III epidermal growth factor receptor mutation in colorectal cancer.
Anticancer Res. 2006 Nov-Dec;26(6C):4889-93.
6
The clinical significance of circulating tumor cells in the peripheral blood.
Diagn Mol Pathol. 2006 Dec;15(4):187-94. doi: 10.1097/01.pdm.0000213463.98763.b9.
7
Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.
Clin Cancer Res. 2006 Nov 1;12(21):6403-9. doi: 10.1158/1078-0432.CCR-05-1769.
8
Epidermal growth factor receptor and epidermal growth factor receptor variant III gene expression in metastatic colorectal cancer.
Clin Colorectal Cancer. 2006 Sep;6(3):214-8. doi: 10.3816/CCC.2006.n.038.
9
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
Clin Colorectal Cancer. 2006 Jul;6(2):125-32. doi: 10.3816/CCC.2006.n.029.
10
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival.
Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4218-24. doi: 10.1158/1078-0432.CCR-05-2821.
Zotero 插件